Ultimate Medical Academy to Hold K-20 Education Summit With 300 Educational Leaders and Advocates on March 23-25, 2017 in Tampa

TAMPA, Fla., March 22, 2017 /PRNewswire-USNewswire/ --

WHO and WHAT: Ultimate Medical Academy is hosting an inaugural K-20 Education Summit (#UMAK20) on March 23- 25, 2017 in Tampa with 300 educational leaders and advocates. They will explore the K-20 Summit theme, "all means ALL," a reference to facilitating equality, advocacy and progress in education.

The K-20 Summit will feature:

  • Three keynote speakers – Dr. Michelle R. Weise, executive director of the Sandbox Collaborative, the R&D arm of strategy and innovation at Southern New Hampshire University, Dr. Jamila Lyiscott, postdoctoral fellow at the Institute for Urban and Minority Education of Teachers College, Columbia University, and Chris Lehmann, founding principal of the Science Leadership Academy, a progressive science and technology high school in Philadelphia;
  • A panel of experts discussing "Access without progress is an empty promise." 
  • 20 breakout sessions in a three-track series – Leadership, Student Services, and Curriculum and Instruction;
  • 22 roundtable discussions on emerging promising practices to support the success of traditionally underserved students; and
  • UMA's Spring Commencement, recognizing 4,000 graduates.

WHERE and WHEN:

  • 1:30 – 4 p.m. March 23, at UMA, 3101 W. Dr. Martin Luther King Jr. Blvd.
  • 9 a.m.5:30 p.m. March 24 at the Grand Hyatt Tampa Bay, 2900 Bayport Dr.
  • 11 a.m.1 p.m. March 25 at the USF Sun Dome, 4202 E. Fowler Ave.

WHY: Thought leaders among the driving forces for innovation in online and blended learning will present compelling keynote lectures on the topics of greatest importance to ensuring student engagement and success.

The K-20 Summit is being sponsored by WUSF Public Media and the Florida Association of Postsecondary Schools and Colleges and co-sponsored by Pearson, Bookmasters, McGraw-Hill, Elsevier, Hobsons, and PAHCOM. Attendees will be able to earn continuing education credits from FAPSC.

ABOUT ULTIMATE MEDICAL ACADEMY:
Ultimate Medical Academy is a nonprofit healthcare educational institution with a national presence. Headquartered in Tampa, Fla. and founded in 1994, UMA offers content-rich, interactive online courses as well as hands-on training at our campuses. UMA students have access to academic advising, one-on-one or group tutoring, résumé and interview coaching, job search assistance, technical support and more. The institution is accredited by the Accrediting Bureau of Health Education Schools (ABHES). Learn more by visiting UltimateMedical.edu.

SOURCE Ultimate Medical Academy

Ventas Announces Pricing of Senior Notes

CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today the pricing of the public offering of $400 million aggregate principal amount of 3.10% senior notes due 2023 and $400 million aggregate principal amount of 3.85% senior notes due 2027 (collectively, the “Notes”) by Ventas Realty, Limited Partnership, its wholly owned subsidiary. The Notes will be guaranteed, on a senior unsecured basis, by the Company. The sale of the Notes is expected to close on March 29, 2017, subject to customary closing conditions.

The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes, which may include funding acquisitions and investments or repaying indebtedness.

The offering is being made pursuant to the Company’s existing shelf registration statement, which is available at no charge at the website of the Securities and Exchange Commission (the “SEC”) at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering. When available, copies of the prospectus supplement and accompanying prospectus relating to the offering may be obtained from: Merrill Lynch, Pierce, Fenner & Smith Incorporated at NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attn: Prospectus Department, or by telephone at (800) 294-1322, or by email at dg.prospectus_requests@baml.com; or J.P. Morgan Securities LLC at 383 Madison Ave., New York, NY 10179, Attn: Investment Grade Syndicate Desk, or by telephone at (212) 834-4533, or by fax at 212-834-6081.

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,300 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, skilled nursing facilities, specialty hospitals and general acute care hospitals. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s or its tenants’, operators’, borrowers’ or managers’ expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, merger or acquisition integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust (“REIT”), plans and objectives of management for future operations and statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from the Company’s expectations. The Company does not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made.

The Company’s actual future results and trends may differ materially from expectations depending on a variety of factors discussed in the Company’s filings with the SEC. These factors include without limitation: (a) the ability and willingness of the Company’s tenants, operators, borrowers, managers and other third parties to satisfy their obligations under their respective contractual arrangements with the Company, including, in some cases, their obligations to indemnify, defend and hold harmless the Company from and against various claims, litigation and liabilities; (b) the ability of the Company’s tenants, operators, borrowers and managers to maintain the financial strength and liquidity necessary to satisfy their respective obligations and liabilities to third parties, including without limitation obligations under their existing credit facilities and other indebtedness; (c) the Company’s success in implementing its business strategy and the Company’s ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions and investments; (d) macroeconomic conditions such as a disruption of or lack of access to the capital markets, changes in the debt rating on U.S. government securities, default or delay in payment by the United States of its obligations, and changes in the federal or state budgets resulting in the reduction or nonpayment of Medicare or Medicaid reimbursement rates; (e) the nature and extent of future competition, including new construction in the markets in which the Company’s seniors housing communities and medical office buildings (“MOBs”) are located; (f) the extent and effect of future or pending healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (g) increases in the Company’s borrowing costs as a result of changes in interest rates and other factors; (h) the ability of the Company’s tenants, operators and managers, as applicable, to comply with laws, rules and regulations in the operation of the Company’s properties, to deliver high-quality services, to attract and retain qualified personnel and to attract residents and patients; (i) changes in general economic conditions or economic conditions in the markets in which the Company may, from time to time, compete, and the effect of those changes on the Company’s revenues, earnings and funding sources; (j) the Company’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; (k) the Company’s ability and willingness to maintain its qualification as a REIT in light of economic, market, legal, tax and other considerations; (l) final determination of the Company’s taxable net income for the year ended December 31, 2016 and for the year ending December 31, 2017; (m) the ability and willingness of the Company’s tenants to renew their leases with the Company upon expiration of the leases, the Company’s ability to reposition its properties on the same or better terms in the event of nonrenewal or in the event the Company exercises its right to replace an existing tenant, and obligations, including indemnification obligations, the Company may incur in connection with the replacement of an existing tenant; (n) risks associated with the Company’s senior living operating portfolio, such as factors that can cause volatility in the Company’s operating income and earnings generated by those properties, including without limitation national and regional economic conditions, development of new, competing properties, costs of food, materials, energy, labor and services, employee benefit costs, insurance costs and professional and general liability claims, and the timely delivery of accurate property-level financial results for those properties; (o) changes in exchange rates for any foreign currency in which the Company may, from time to time, conduct business; (p) year-over-year changes in the Consumer Price Index or the U.K. Retail Price Index and the effect of those changes on the rent escalators contained in the Company’s leases and on the Company’s earnings; (q) the Company’s ability and the ability of its tenants, operators, borrowers and managers to obtain and maintain adequate property, liability and other insurance from reputable, financially stable providers; (r) the impact of increased operating costs and uninsured professional liability claims on the Company’s liquidity, financial condition and results of operations or that of the Company’s tenants, operators, borrowers and managers, and the ability of the Company and the Company’s tenants, operators, borrowers and managers to accurately estimate the magnitude of those claims; (s) risks associated with the Company’s MOB portfolio and operations, including the Company’s ability to successfully design, develop and manage MOBs and to retain key personnel; (t) the ability of the hospitals on or near whose campuses the Company’s MOBs are located and their affiliated health systems to remain competitive and financially viable and to attract physicians and physician groups; (u) risks associated with the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition; (v) the Company’s ability to obtain the financial results expected from its development and redevelopment projects; (w) the impact of market or issuer events on the liquidity or value of the Company’s investments in marketable securities; (x) consolidation in the seniors housing and healthcare industries resulting in a change of control of, or a competitor’s investment in, one or more of the Company’s tenants, operators, borrowers or managers or significant changes in the senior management of the Company’s tenants, operators, borrowers or managers; (y) the impact of litigation or any financial, accounting, legal or regulatory issues that may affect the Company or its tenants, operators, borrowers or managers; and (z) changes in accounting principles, or their application or interpretation, and the Company’s ability to make estimates and the assumptions underlying the estimates, which could have an effect on the Company’s earnings.

Click here to subscribe to Mobile Alerts for Ventas, Inc.

DNA Sequencing Market Growth Opportunities, Sales, Revenue, Consumptions, Industry Analysis and Forecasts 2022

In this report, the global DNA Sequencing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

DNA Sequencing Market is expected to witness growth of international market with respect to advancements and innovations including development history, competitive analysis and regional development forecast.

The report starts with a basic DNA Sequencing market overview. In this introductory section, the research report incorporates analysis of definitions, classifications, applications and industry chain structure.

In depth analysis of DNA Sequencing Market is a crucial thing for various stakeholders like investors, CEOs, traders, suppliers and others.

DNA Sequencing Market split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

  • First Generation DNA Sequencing
  • Second Generation DNA Sequencing
  • Third Generation DNA Sequencing

DNA Sequencing Market split by application, report focuses on consumption, market share and growth rate of DNA Sequencing in each application and can be divided into

  • Oncology DNA Sequencing
  • Life Science DNA Sequencing
  • Emerging Application DNA Sequencing
  • Hereditary Disease Detection DNA Sequencing

Browse more detail information about DNA Sequencing Market at: http://www.360marketupdates.com/10536392

To begin with, the report elaborates the DNA Sequencing Market overview. Various definitions and classification of the industry, applications of the industry and chain structure are given. Present day status of the DNA Sequencing Market in key regions is stated and industry policies and news are analysed.

Next part of the DNA Sequencing Market analysis report speaks about the manufacturing process. The process is analysed thoroughly with respect three points, viz. raw material and equipment suppliers, various manufacturing associated costs (material cost, labour cost, etc.) and the actual process.

Following are the key players covered in this DNA Sequencing Market research report:

  • Illumina
  • Roche
  • Macrogen
  • BGI
  • WuXi AppTec
  • DAAN GENE
  • Novo Gene
  • Berry Genomics
  • Biomarker
  • Majorbio
  • CapitalBio Genomics
  • Anoroad

And Many Others……

Get a PDF Sample of DNA Sequencing Market Research Report at: http://www.360marketupdates.com/enquiry/request-sample/10536392

After the basic information, the DNA Sequencing Market report sheds light on the production. Production plants, their capacities, global production and revenue are studied. Also, the DNA Sequencing Market growth in various regions and R&D status are also covered.

Following are Major Table of Content of DNA Sequencing Industry:

• DNA Sequencing Market Competition by Manufacturers

• DNA Sequencing Production, Revenue (Value) by Region (2017-2022)

• DNA Sequencing Supply (Production), Consumption, Export, Import by Regions (2017-2022)

• DNA Sequencing Production, Revenue (Value), Price Trend by Type

• DNA Sequencing Market Analysis by Application

• DNA Sequencing Manufacturers Profiles/Analysis

• DNA Sequencing Manufacturing Cost Analysis

• Industrial Chain, Sourcing Strategy and Downstream Buyers

Further in the DNA Sequencing Market Industry Analysis report, the DNA Sequencing Market is examined for price, cost and gross capacity. These three points are analysed for types, companies and regions. In continuation with this data sale price for various types, applications and region is also included. The DNA Sequencing Market for major regions is given.

Scope of the DNA Sequencing Industry on the basis of region:

  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India

Additionally, type wise and application wise consumption figures are also given. With the help of supply and consumption data, gap between these two is also explained.

To provide information on competitive landscape, this report includes detailed profiles of DNA Sequencing Market key players. For each player, product details, capacity, price, cost, gross and revenue numbers are given. Their contact information is provided for better understanding.

In DNA Sequencing Market report analysis, traders and distributors analysis is given along with contact details. For material and equipment suppliers also, contact details are given. New investment feasibility analysis and DNA Sequencing Market Industry growth is included in the report.

No. of Report Pages: 112

Price of Report (Single User Licence): $4000

Purchase DNA Sequencing Market Report at:http://www.360marketupdates.com/purchase/10536392

About 360 Market Updates:

360 Market Updates is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.

Contact

Mr. Ameya Pingaley

360 market Updates

+1-408 520 9750

Email – sales@360marketupdates.com

Exploring Behavioral Medicine: Its Application to Anxiety & Depression Disorders

ADAA logo

ADAA 2017 Annual Conference

Conference attendees will take away a much greater sense of the variety of mental health treatments for their patients who need help now and in the future.”

— ADAA President Karen Cassiday,PhD

SAN FRANCISCO, CA, USA, March 22, 2017 /EINPresswire.com/ — Anxiety disorders affect 40 million adults and one in eight children in the United States. They interfere with daily functioning and often lead to depression, substance use, suicide attempts, and other disorders.

Depressive disorders affect about 19 million American adults. More than 50 percent of people diagnosed with depression also have an anxiety disorder. Coexisting anxiety and depression account for the most disabling mental health disorders in the United States.

One of the most pressing issues facing mental health professionals is behavioral medicine and its application to anxiety and depression disorders – and what this means for patients and their families. Experts will discuss these and other relevant topics when they convene at the Anxiety and Depression 2017 Conference. Sponsored by the Anxiety and Depression Association of America (ADAA), the conference draws more than 1,200 clinicians and researchers who specialize in anxiety, depression, PTSD, OCD and other related disorders. Under the theme “On the Cutting Edge of Wellness,” they will meet April 6-April 9 at the Hilton San Francisco Union Square.

Distinguished therapists and psychiatrists from around the globe will focus on the challenges facing those who treat anxiety and mood disorders. These are among the best understood brain disorders, and effective evidence-based psychological and pharmacological treatments are available.

“Patients often have questions about whether they are receiving the most appropriate care for mood and anxiety disorders,” says ADAA President Karen Cassiday, PhD, a psychologist at the Anxiety Treatment Center and Rogers Behavioral Health Chicago, “even though a wide range of evidence-based mental health interventions are available.” She explains, “Scientific research leads to new and novel treatment approaches, so clinicians are faced with more and more information all the time.” Those who attend the conference will take away a much greater sense of the variety of mental health treatments for their patients who need help now — and in the future.

University of Nevada Foundation Professor of Psychology and one of the world’s most-cited clinical research psychologist and psychotherapy developer, Steven C. Hayes, PhD, will deliver the keynote address, “The Power of Turning Toward: Why Psychological Flexibility Matters for Clients and Practitioners Alike.” Dr. Hayes will describe the science of psychological flexibility as a general model of behavioral development and change and show why it matters to target these processes for change for clients and for the practitioners who serve them.
Many of the world’s most experienced and knowledgeable clinicians and researchers will also address other issues related to anxiety and depression, among them mindfulness, trauma, substance abuse, ketamine therapy, suicide, the use of mental health apps, alternative therapies, telemental health, veteran-focused therapy, new and novel pharmacotherapies, selective mutism, anxious children and culturally sensitive therapy for minority and LGBTQ communities.
For more details on the more than 170 workshops, symposia, and roundtables, visit the ADAA website: www.adaa.org/conference.
The media will have opportunities to interview experts and attend all sessions. A complete list of sessions and new-research posters, including abstracts, is available online.

The Anxiety and Depression Association of America (ADAA) is the leading national nonprofit organization dedicated to promoting the prevention, treatment, and cure of anxiety, depression, PTSD, OCD and related disorders through advocacy, education, training and research. Visit www.adaa.org

Lise Bram
ADAA
2404851016
email us here

ADAA 2017 Conference

[embedded content]

Lanthanum Hexaborid Market Trends and Opportunities by types and Application in Grooming Regions; Edition 2017-2022

Lanthanum Hexaborid Market Report Forecast 2017-2021 is a valuable source of understanding data for business strategists. It provides the Lanthanum Hexaborid industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Lanthanum Hexaborid market study provides comprehensive data which enhances the understanding, scope and application of this report.

Lanthanum Hexaborid Market report provides full analysis of Key market segments and sub-segments, growing market trends and dynamics Changing supply and demand scenarios, calculating market opportunities through market sizing and market forecasting, Tracking current trends/opportunities/challenges, Opportunity mapping in terms of technological breakthroughs.

Major Topics Covered in Lanthanum Hexaborid Market Research Report:

  • Market Forecast 2017-2021
  • Economic Impact
  • Manufacturer Landscape
  • Industrial Chain, Sourcing Strategy and Downstream Buyers
  • Lanthanum Hexaborid Market Analysis by Application & Type
  • Volume, Value and Price Analysis with respect to Countries
  • Marketing Strategy Analysis, Distributors/Traders
  • Market Effect Factors Analysis

Ask Sample PDF @ https://www.360marketupdates.com/enquiry/request-sample/10526203

Top Manufacturers of Lanthanum Hexaborid Market:

  • Materion Corporation
  • JAPAN NEW METALS
  • Treibacher Industrie AG
  • Stanford Advanced Materials
  • C. Starck
  • Shanghai Naiou Nanotechnology
  • Shanghai St-nano Science and Technology

Global Lanthanum Hexaborid market report provides the manufacturers analysis and a corresponding detailed analysis of the major manufacturers operating in the Lanthanum Hexaborid industry. For each manufacturer product details, capacity, price, cost, gross and revenue numbers are given.

Lanthanum Hexaborid Market by Regions:

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

Lanthanum Hexaborid Market Effect Factors Analysis:

  • Technology Progress/Risk
  • Technology Progress in Related Industry
  • Consumer Needs/Customer Preference Change
  • Economic/Political Environmental Change
  • Substitutes Threat

Global Lanthanum Hexaborid market report provides the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.

For More Enquiry, Ask Experts @ https://www.360marketupdates.com/enquiry/pre-order-enquiry/10526203

Reasons for Buying this Report:

  • It provides a forward-looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed based on how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Total No of Pages:117

Price: $2800 (Single User Licence)

Purchase this Report @ https://www.360marketupdates.com/purchase/10526203

The report evaluates 2017-2021 market development trends of Lanthanum Hexaborid market. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Lanthanum Hexaborid industry before evaluating its feasibility.

 

About 360 Market Updates:

360 Market Updates is the credible source for gaining the Market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of Market segments.

Contact–

Mr. Ameya Pingaley

360 Market Updates

+1-408 520 9750

Email – sales@360marketupdates.com

www.360marketupdates.com

Industry-leading companies speaking at Parks Associates’ 21st-annual CONNECTIONS(TM): The Premier Connected Home Conference, May 23-25 in San Francisco

/EINPresswire.com/ — DALLAS, TX–(Marketwired – Mar 22, 2017) –  Consumer IoT research firm Parks Associates today announced the keynotes and initial speaker lineup for the 21st-annual CONNECTIONS™: The Premier Connected Home Conference, which will be held May 23-25, in San Francisco, California. The executive conference focuses on ways to engage consumers and grow revenues in the converging IoT industries, including smart home, connected entertainment, and mobile ecosystems. The conference features keynotes by executives from Comcast, Cox Communications, Intel, and Vivint Smart Home and new research from Parks Associates.

Parks Associates research shows that innovators and early adopters are driving the smart home market, and this group is adopting solutions for safety, security, and access control. While the security industry remains the leading channel for smart home services, consumers are adopting point solutions in increasing numbers.

„As smart home solutions expand into new product categories, smart home service providers need to expand their ecosystem to keep up with the consumer,” said Elizabeth Parks, Senior Vice President, Parks Associates. „CONNECTIONS™ addresses the overall market for the connected consumer, including new use cases, product features, and evolving business models that will successfully engage consumers and increase adoption of products in multiple IoT industries.”

The 21st-annual event, which will be held at the Hyatt Regency San Francisco Airport, will include the following keynote speakers:

  • Matt Eyring, Chief Strategy and Innovation Officer, Vivint Smart Home
  • Kristine Faulkner, Senior Vice President / General Manager, COX Homelife, Cox Communications
  • Miles Kingston, GM of Smart Home, Intel
  • Sridhar Solur, Senior Vice President, Product & Development for Xfinity Home, Internet of Things and Data Services, Comcast

„The smart home is forcing convergence of traditionally separate industry silos, and partnerships are driving new value as integrated and flexible solutions offer a variety of unique user experiences,” said Tom Kerber, Director, IoT Strategy, Parks Associates. „With more than 650 executives in attendance at CONNECTIONS™, we will shine the spotlight on new partnerships and share new business models, technology innovations, and monetization opportunities.”

„Generating enthusiasm around home energy management comes down to providing consumers with meaningful data, which is increasingly challenging as the volume of information produced by connected home IoT devices and sensors continues to grow,” said Amena Ali, Chief Revenue Officer, Whisker Labs. „At CONNECTIONS™: The Premier Connected Home Conference, we look forward to discussing strategies to get consumers excited about energy management, deepening their engagement and incentivizing them to take action.”

„Delivering customer value via IoT analytics and data science is the next big opportunity for smart home providers. Manufacturers who will be able to improve product design, accelerate adoption, and enhance user experience — using insights from connected product data — will eventually lead the smart home space,” said Jennifer Sewell, Head of Product Marketing at mnubo, a leading IoT analytics solution provider. „I am excited to partake in the Parks Associates’ CONNECTIONS™ event to meet leading consumer IoT and smart home brands and discuss how data-driven insights can help them differentiate and take their value-proposition to the next-level.”

Additional confirmed speakers include:

  • Amena Ali, Chief Revenue Officer, Whisker Labs
  • Greg Berkin, Managing Director, Concours Ventures
  • Dan Berte, Director, IoT, Bitdefender
  • Oliver Cockcroft, Product Architect, Ayla Networks
  • Jay Darfler, SVP Emerging Markets, ADT
  • Casper de Clercq, General Partner, Norwest Venture Partners
  • Dan DiClerico, Smart Home Advisor, HomeAdvisor
  • Justin Doucette, Sr. Dir, Product Management, Linksys & Wemo, Belkin International
  • Scott P. Ford, CEO, Pepper IoT
  • Seth Frader-Thompson, Co-founder and President, EnergyHub, Inc.
  • Luke Freiler, CEO, Centercode
  • William Greene, Product Manager, Energy Services, Nest Labs
  • Kal Gyimesi, Automotive Marketing Leader, IBM Watson IoT
  • Kurt Hoppe, Global Head of Innovation – Connected Car, GM
  • Hakan Kostepen, Executive Director – Product Strategy & Innovation, Panasonic
  • Greg Kruczek, Director of New Ventures, Asurion
  • Ryan Lester, Director, IoT Strategy, LogMeIn
  • Joe Liu, CEO, MivaTek
  • Stuart Lombard, Founder & CEO, ecobee
  • Arlen Marmel, VP Marketing & Distribution, Ellation
  • Elizabeth Mathes, Director of Smart Home, The Home Depot
  • David Meyers, Chief Commercial Officer, Grid4C
  • Lainie Muller, Director, Wellness, Alarm.com
  • Kelemen Papp, Executive Director, Mooreland Partners
  • Jeff Patton, GM Connected Home Products, GE Lighting
  • Duane Paulson, SVP-Strategic Development, Nortek Security & Control
  • Peter Radsliff, VP, Marketing, Arrayent
  • Tom Rivers, VP, Connected Car Marketing, Harman
  • Jerome Rota, Chief Scientist, Usability, Greenwave Systems
  • Jennifer Sewell, Head of Product Marketing, mnubo – IoT Analytics
  • Michael Yang, Managing Director, Comcast Ventures

Moderators / Analysts:

  • Dina Abdelrazik, Research Analyst, Parks Associates
  • Glenn Hower, Senior Analyst, Parks Associates
  • Jennifer Kent, Director, Research Quality & Product Development, Parks Associates
  • Tom Kerber, Director, IoT Strategy, Parks Associates
  • Brad Russell, Research Analyst, Parks Associates
  • Patrice Samuels, Senior Analyst, Parks Associates
  • Brett Sappington, Senior Director of Research, Parks Associates
  • Harry Wang, Senior Director of Research, Parks Associates

Parks Associates will also host three pre-show workshops on May 23, led by the firm’s senior IoT analysts, on the following topics:

The workshops will include the latest research and industry analysis from Parks Associates. Recent data from the leading consumer IoT research firm includes the following:

  • One-third of newly acquired home security systems are self-installed.
  • 26% of U.S. broadband households own a smart home device; 11% of U.S. broadband households own a smart thermostat.
  • 5% of U.S. broadband households own a smart plug/adapter module.
  • U.S. broadband households with smart light bulbs own 2.4 of these products on average.
  • 19% of U.S. broadband households plan to buy a smart major appliance in the next 12 months.
  • 70% of U.S. broadband households with smart energy devices report saving money due to reduced energy consumption.
  • 42% of U.S. broadband households would select electric utilities as their first choice for energy management services.
  • 51% of U.S. broadband households find an IoT device that alerts them to smoke and fire highly appealing and 41% find a device that alerts them to a water leak to be highly appealing.
  • More than 30 million U.S. broadband households will have a home security system by 2019.
  • 11% of U.S. broadband households now have a smart watch, and approximately one million use their watch to control devices.
  • 18% of U.S. broadband households own a wearable fitness device such as a smart watch or fitness tracker.
  • Two-thirds of wearable fitness device owners use the device daily or almost daily.

To register for the 21st-annual CONNECTIONS™ conference and a pre-show workshop, visit http://bit.ly/CONNUSregistration. To schedule an interview with an analyst or request specific research, contact Holly Sprague at hsprague@gmail.com, 720.987.6614.

About CONNECTIONS™
Parks Associates’ 21st-annual CONNECTIONS™: The Premier Connected Home Conference will take place May 23-25 at the Hyatt Regency San Francisco Airport in San Francisco. CONNECTIONS™ is the premier connected home event hosting over 700 executives from the connected entertainment, IoT, and smart home industries. The event provides a day of pre-show research workshops highlighting Parks Associates’ consumer data and analysis and two days of conference sessions focused on technology adoption and trends, forecasts for new products and services, evaluation of new business strategies, and recommendations about technology innovations, strategic partnerships, monetization opportunities, and value-added services.

The event provides executive networking opportunities and insights from industry leaders on entertainment, mobile, and smart home market segments. Throughout the event, sponsors offer tabletop demos during networking events, spotlighting new technology innovations and services.

For more information, contact sales@parksassociates.com, call 972-490-1113, visit www.connectionsconference.com.

Market Demand Drives Drake Plastics Medical Expansion

/EINPresswire.com/ — CYPRESS, TX–(Marketwired – March 22, 2017) – Drake Plastics announces both the capacity and facility expansion of Drake Plastics Medical Products Ltd. Co.

Since inception in February 2016, Drake Plastics Medical has served key customers as both a supplier of specialty medical grade polymers and as a contract manufacturer of medical devices. To accommodate growth, ground breaking for two new buildings dedicated to Drake Plastics Medical is scheduled for April 2017. This will add 24,000 square feet (2200 square meters) of new manufacturing space at Drake’s 45-acre Cypress, Texas campus. Completion of this expansion is scheduled for August 2017 according to Joey King, Drake’s Project and Facilities Manager. Strong market acceptance and growth in the demand for medical conversion is driving the need for additional manufacturing space.

According to Drake’s President, Steven Quance, „Last year we made the decision to apply a dedicated focus toward medical customers. Although Drake Plastics has served medical applications for over a decade, our focus over the past year has been to ‚lean into’ the needs of medical customers from both a supply and quality assurance standpoint. These steps, coupled with our broad capabilities in extrusion, injection molding, precision fabrication and development provide a compelling case for customer engagement which has been validated by new opportunities.”

Regarding quality systems, Kathy Oliveto, Business Manager for Drake Plastics Medical has noted, „Our site is FDA registered as a device manufacturing location and we expect to obtain ISO 13485 certification in 2017. Presently our quality management system is certified to ISO 9001-2008.”

Drake Plastics Medical currently occupies 5000 square feet of dedicated medical manufacturing space. Within this facility are Drake custom designed extruders, dedicated dryers, annealing ovens along with precision fabrication equipment. Capabilities include rod diameters from 2 to 150 mm and flat stock from 10 mils to 25 mm thicknesses. The medical cell’s capabilities range from the conversion of pellets through to final devices with total traceability within the confines of a single facility.

About Drake Plastics Medical Products

Drake Plastics Medical is organized to be a „one-stop shop” for specialty polymers for prototyping to higher volumes of parts made via multiple conversion techniques including machining or and injection molding of PEEK, AvaSpire® PAEK, Amodel, IXEF and Torlon®. Drake also provides stock shapes made from many FDA compliant resins that are well suited for non-implant medical and life science applications. Additionally, Drake’s Process Development Team converts custom formulations, providing customers with customized and confidential conversion services for both implantable and non-implantable polymers, quickly and economically.

About Drake Plastics

Founded in 1996, Drake Plastics pioneered the production of stock shapes from glass reinforced Torlon® 5030 in support of the Javelin Missile Program. Drake offers a continually expanding portfolio of machinable shapes, injection molded parts and precision machined components from Torlon® and specialty PEEK. Drake is an ISO 9001-2008 registered, lean manufacturer. Waste and inefficiency are relentlessly driven out contributing to Drake’s ability to develop and produce unique, high quality engineering plastic products. Drake delivers to customers around the world, on time with exceptional service and support.

Learn more at www.drakeplasticsmedical.com and www.drakeplastics.com Drake Plastics Ltd. Co., The Torlon® Specialists, Drake Research Ltd., and The Specialty PEEK Specialists, use the Seamless Tube® Trademark under license from Drake Plastic Products Inc.

Image Available: http://www.marketwire.com/library/MwGo/2017/3/20/11G133550/Images/Torlon-PEEK_Medical-8281de86c969b2c4826b9a21628fc52d.jpg

World Water Day — Ten Reasons Why Wastewater Should Not Be „Wasted”

/EINPresswire.com/ — CAMBRIDGE, ON–(Marketwired – March 22, 2017) – World Water Day is a great time to reflect on how fortunate those of us that have clean, safe, drinking water really are. Much of the world is not so lucky so it is critically important that we think about how we care for our precious, water resources.

While having quality drinking water is more appreciated than ever, wastewater is still often viewed as „waste.” We are honored and excited to be part of a team that is working hard to change this perception with innovative, safe and efficient solutions for better use of wastewater resources.

Here are 10 good reasons why properly managed wastewater resources should not be wasted:

  1. Scarcity of water. Salt water is plentiful, but fresh water is scarce. Failing to re-use wastewater means failing to maximize a valuable resource. Recycling of wastewater through scientifically advanced resource recovery systems puts much-needed clean water back into circulation.
  2. Safe water. One tenth of the world’s population lacks access to clean, safe water. When un-treated sewers run through communities, they undermine health and well-being, trapping many people in a cycle of poverty. Conversely, when proper wastewater treatment systems are in place, they allow for the removal of bacteria and other contaminants so clean water can flow through communities that need it, thereby helping organizations like World Help save lives.
  3. Energy from wastewater. Advanced, technical solutions can also be used to increase the production of biogas in digesters at wastewater treatment plants. This remarkable source of alternative energy can help to reduce operational costs, decrease greenhouse gas emissions and even power these facilities thereby converting traditional plants into Wastewater Resource Recovery Centers (WRRC). This can help reduce the negative impacts of climate change.
  4. Fertilizer from wastewater. With today’s technologies, it is also possible to convert biosolids into safe, pathogen-free, nutrient-rich, Class A quality biofertilizers. These products can be ideal for promoting healthy, productive soil and plant life. Converting treatment plants into WRRC’s is a great way to turn wastewater into valuable products.
  5. Diversion of waste from landfills. When treated as „waste,” wastewater biosolids are too often dumped in landfills — more than nine million tons across North America, annually. This practice is not sustainable as it takes up valuable space and sends greenhouse gases into our atmosphere. Conversely, when treated with methods based in sound science and research, the material can be recycled for higher and better uses, reducing the need to create more landfills.
  6. Cost savings & revenue generation. There are wastewater management solutions available today that offer low capital energy and operating costs while producing valuable, much needed products with real market value. Forward thinking generators are already taking advantage of these opportunities to reduce costs and make positive contributions to the circular economy.
  7. Create green spaces. Wastewater resources are now being viewed by many cities as an opportunity to do public good. In Lima, Peru, for example, treated wastewater has played an important role in creating a public park where residents can enjoy rare green space. The water and nutrients stay in the city, providing new benefits in their recycled form.
  8. Lower carbon footprint. Drinking water can be especially vulnerable to the effects of climate change. Responsible wastewater management helps to minimize these risks by using safe, proven approaches to keep the carbon in the ground and reduce greenhouse gas emissions.
  9. Save energy. States like California have already invested a great deal of money and time in finding ways to decrease the amount of energy required to manage precious water resources. Recycling wastewater reduces the amount of energy otherwise required to pump it over long distances for further treatment or disposal, making it part of the energy conservation solution.
  10. Prevent erosion. Recycled wastewater contains valuable nutrients and organic matter that keeps soil healthy. Healthy plants and soils are also able to retain more moisture (i.e. water), thereby reducing the potential for run-off in areas where soil degradation and erosion threaten already-scarce water supplies.

Lystek International Inc. is a leading provider of Thermal Hydrolysis solutions for the sustainable management of biosolids and organics. The multi-use, award-winning Lystek system reduces costs, volumes and GHG’s by converting municipal and industrial wastewater treatment facilities into resource recovery centers. This is achieved by transforming organic waste streams into value-added products and services, such as the patented LysteMize® process for optimizing digester performance, reducing volumes and increasing biogas production; LysteGro®, a high-value, nutrient-rich biofertilizer and LysteCarb®, an alternative source of carbon for BNR systems.

Image Available: http://www.marketwire.com/library/MwGo/2017/3/20/11G133597/Images/Fast-Running_Water-6e7b15a3d1bfac4d9f4e58d0866e6317.jpg

Osage University Partners Announces A New Hire and Promotion

/EINPresswire.com/ — BALA CYNWYD, PA–(Marketwired – March 22, 2017) – Osage University Partners, a venture capital fund that invests in university startups, announced today the promotion of Manny Stockman, PhD, to Senior Associate on the tech investment team, and the addition of Anurag Agarwal, PhD, Associate on the life science investment team.

Dr. Stockman joined Osage University Partners as an Associate in 2015 with an investment focus on hardware, IoT, and computing. Prior to joining the firm, Manny worked at Lockheed Martin, where he led a team of engineers executing on the transition of early stage technologies into the defense industry. He holds a PhD from Princeton University in Applied Physics and Aerospace Engineering.

Dr. Agarwal previously was a consultant at Boston Consulting Group where he worked with healthcare and private equity companies to advise them on corporate growth strategy, business development, portfolio management, and M&A projects. Anurag holds a PhD from Washington University School of Medicine in Molecular Cell Biology.

„We are thrilled to welcome Anurag to our team. His background in both academic research and management consulting is an ideal match to the experience mix we are looking for in our new investment professionals,” said Bill Harrington, Managing Partner at Osage University Partners. „Likewise, Manny’s promotion reflects our firm’s commitment to recognizing excellence. Manny has proven to be very skilled at working with entrepreneurs, professors, and venture capital firms, all of which are critical within our university investment model.”

About Osage University Partners

Osage University Partners is a venture capital firm focused on investing in startups that are commercializing pioneering university technologies. Osage partners with top research universities to invest in their most innovative startups, and Osage shares its investment profit with its partner institutions. The firm invests in software, hardware, and life science companies at all stages of company development. Osage has partnered with 90 universities, including 36 of the top 50 U.S. institutions by research expenditures, and has invested in over 60 of their spinouts. Osage University Partners is part of a family of investment funds within Osage Partners, which is based in Philadelphia, PA and manages in excess of $500 million.

Energous Corporation Adds Nick Alexopoulos and Franco De Flaviis to Its Board of Advisors

SAN JOSE, CA–(Marketwired – March 22, 2017) – Energous Corporation (NASDAQ: WATT), the developer of WattUp®, a revolutionary wire-free charging technology that provides over-the-air power at a distance, today announced the addition of Nick Alexopoulos and Franco De Flaviis to its board of advisors. For more information, visit: http://ir.energous.com/board-of-advisors.

Dr. Nick Alexopoulos most recently served as vice president for Antennas, RF Technologies and University Relations at Broadcom Corporation. Prior to that, he served as the Dean of the Henry Samueli School of Engineering at the University of California at Irvine (UCI), a position he held from 1997 to 2008. Previously, he was a member of the faculty at the Henry Samueli School of Engineering and Applied Science at the University of California at Los Angeles (UCLA) from 1969 to 1996, where he served as Chair of the Electrical Engineering Department between the years 1987 and 1992. While at UCLA, he also served as Associate Dean for Faculty Affairs between 1986 and 1987. Dr. Alexopoulos was elected an IEEE Fellow for his contributions to the understanding of substrate-superstrate effects on printed circuit antennas and integrated microwave circuits. He was elected to the United States National Academy of Engineering for his contributions to microwave circuits, antennas, and structures for low observable technologies, and for contributions in engineering education. Dr. Alexopoulos is highly cited in Computer Science and has received two IEEE Best Journal Paper Awards.

Dr. Franco De Flaviis is a tenured professor at the Department of Electrical Engineering and Computer Science at the University of California at Irvine (UCI). Dr. De Flaviis has been consulting for companies in CMOS passive design, small form factor antennas, and phased array systems. He was a long-time consultant to Broadcom Corporation working on antenna design and CMOS passives and has also previously consulted for Motorola Inc., Atlantic Aerospace, and various small start-up, high tech companies. Dr. De Flaviis has authored and co-authored over 200 papers in refereed journals and conference proceedings, filed several international patents and authored one book and three book chapters. He is a member of the URSI Commission B and was elected to the grade of IEEE Fellow in 2014. His research interests include the development of microelectromechanical systems (MEMS) for RF applications fabricated on unconventional substrates such as printed circuit board and microwave laminates, with particular emphasis on reconfigurable antenna and front-end systems. He is also active in the research field of highly integrated packaging for RF and wireless applications and small size, low-cost antenna array for personal communication systems and vehicle. Dr. De Flaviis received his degree (Laurea „Summa Cum Laude”) in electronics engineering from the University of Ancona in Italy in 1990. He was a visiting student in 1991 at the University of California at Los Angeles (UCLA) working on ultralow distortion resistive mixers. Dr. De Flaviis then received his M.S. and Ph.D. degree in electrical engineering from the Department of Electrical Engineering at UCLA in 1994 and 1997 respectively, followed by his post-doctoral fellowship on full-wave analysis of nonlinear dielectrics for microwave structures in 1998.

„Antennas and RF technology are core elements of our industry-leading WattUp wireless power technology. Adding Nick and Franco to our Advisory Board enables Energous to draw upon their considerable experience and expertise as we continue to enhance and advance our technology,” said Stephen R. Rizzone, president and CEO of Energous. „Nick and Franco’s high standing in the international engineering community will also serve as a beacon to draw additional top engineering talent to our world-class development organization. We are very fortunate to have the benefit of their guidance and support.”

About Energous Corporation

Energous Corporation is the developer of WattUp® — an award-winning, wire-free charging technology that will transform the way consumers and industries charge and power electronic devices at home, in the office, in the car and beyond. WattUp is a revolutionary radio frequency (RF) based charging solution that delivers intelligent, scalable power via radio bands, similar to a Wi-Fi router. WattUp differs from older wireless charging systems in that it delivers contained power, at a distance, to multiple devices — thus resulting in a wire-free experience that saves users from having to remember to plug in their devices. For more information, please visit Energous.com.

Follow Energous

Facebook: https://www.facebook.com/energous/

Twitter: @energous

LinkedIn: https://www.linkedin.com/company/energous-corporation

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the „safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as „believe,” „expect,” „may,” „will,” „should,” „could,” „seek,” „intend,” „plan,” „estimate,” „anticipate” or other comparable terms. All statements in this release that are not based on historical fact are „forward-looking statements.” Examples of forward-looking statements include, among others, statements we make regarding expectations for future revenue, market developments, technological advances, anticipated results of our development efforts, and the timing for receipt of required regulatory approvals and product launches. While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to develop a commercially feasible technology; receipt of necessary regulatory approvals; our ability to find and maintain development partners and licensees, market acceptance of our technology, the amount and nature of competition in our industry; our ability to protect our intellectual property; and the other risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.